Dr. Tobin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2601 N 3rd St
Suite 125
Phoenix, AZ 85004Phone+1 602-265-6500
Education & Training
Barrow Neurological Institute at St Joseph's Hospital and Medical CenterResidency, Neurology, 1999 - 2002
Creighton University School of Medicine (Phoenix)Internship, Internal Medicine, 1998 - 1999
Saint Louis University School of MedicineClass of 1998
Certifications & Licensure
AZ State Medical License 1999 - 2026- American Board of Psychiatry and Neurology Neurology
Clinical Trials
- A Study of Galcanezumab (LY2951742) in Participants With Migraine Headache Start of enrollment: 2014 Jul 07
- A Study of LY3451838 in Participants With Migraine Start of enrollment: 2020 Nov 16
- A Study of Galcanezumab (LY2951742) in Participants 12 to 17 Years of Age With Chronic Migraine Start of enrollment: 2020 Nov 25
Publications & Presentations
PubMed
- 61 citationsOccipital Nerve Blocks: When and What to Inject?Joshua Tobin, Stephen Flitman
Headache. 2009-11-01 - 19 citationsHypomagnesemic Seizures: Case Report and Presumed PathophysiologyPedro Weisleder, Joshua A. Tobin, John F. Kerrigan, John B. Bodensteiner
Journal of Child Neurology. 2002-01-01 - 36 citationsOccipital nerve blocks: effect of symptomatic medication: overuse and headache type on failure rate.Joshua Tobin, Stephen Flitman
Headache. 2009-11-01
Press Mentions
Senior Celebration Highlights the Accomplishments of the Class of 2024May 16th, 2024
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
